header bar
  LeukemiaLinks - Your Link to the Latest Leukemia News  


APRIL 2009 800.955.4572 Email the IRC Forward to a Friend
 

Welcome to LeukemiaLinks, your monthly source of leukemia news, research updates, clinical trials and events sponsored by The Leukemia & Lymphoma Society (LLS). For even more information, regularly visit our Patient Services and Disease Information Web sections.

news image

Latest Leukemia News

Low-Dose Azacitidine Better Tolerated by Myelodysplastic Syndrome Patients
The use of a less intensive azacitidine dosing schedule than the current standard in patients with lower-risk myelodysplastic syndrome is better tolerated, and still provides treatment advantages::READ MORE NEWS::

LLS Features    ::READ MORE::
.....................................................................................................................................

Research Roundup
   ::READ MORE::
.....................................................................................................................................
IRC Question of the Month   
::READ MORE::


Inspirational Stories

Inspirational ImageLearn how individuals touched by blood cancer cope. The LLS LifeMosaic Web feature offers hundreds of inspiring stories by patients and families. Read them or submit your own. This month, read about Steve Dianis.

Here to Help

For even more information, regularly visit the LLS Web site,
www.LLS.org, where many of our education programs are archived free of charge for convenient access 24/7.

If you haven't found what you're looking for in LeukemiaLinks , please call our Information Resource Center (IRC) to speak with trained information specialists. IRC staff are available Monday through Friday, 9 a.m. to 6 p.m. ET, toll free at (800) 955-4572; email
infocenter@lls.org; or click the "Live Patient Help" button on the www.LLS.org homepage.

Honor Your Mother - Support Lifesaving Research

 

Researcher Image

Commentary
Deborah Banker, Ph.D., shares more news on cancer stem cells.

 


Clinical Trials

We invite you to use our LLS-supported TrialCheck® Web site , a clinical trial search service that offers patients and caregivers immediate access to listings of all leukemia clinical trials. Answer just a few simple questions and a list of available clinical trials related to your cancer will appear in an easy to read list of search results. 

You may also want to visit the National Cancer Institute's Cancer Trials Support Unit, providing resources and information on Phase III cancer treatment trials supported by the National Cancer Institute. :: SELECTED TRIALS::



Newsfeeds & Podcasts

Now you can get RSS Feeds and Podcasts from LLS.
:: CLICK HERE TO SIGN UP::

RSS - XML - Podcast - iTunes

Free eNewsletters
Free LLS eNewsletters deliver the latest information on research and treatment options, patient services programs and fundraising events.
:: CLICK HERE TO SIGN UP::


bottom bar

Latest Leukemia News

news image

Alternative To Biopsy Detects Subtle Changes In Cancer Cells
Study supported by The Leukemia & Lymphoma Society.  A drop of blood or a chunk of tissue smaller than the period at the end of this sentence may one day be all that is necessary to diagnose cancers and assess their response to treatment.

> Back to the top

LLS Features

calendar image


CML: Understanding Treatment, Monitoring Response
Register now for this free telephone education program on Tuesday, May 19, noon - 1:00 p.m. ET. The guest speaker is Eric J. Feldman, M.D., of Weill Cornell Medical College, New York-Presbyterian Hospital
 
My Personal CML Journey
LLS is proud to offer My Personal CML Journey, an interactive, online video education program. The feature follows the stories and experiences of two chronic myelogenous leukemia (CML) survivors. Learn more.

Personal Clinical Trials Journey
Participate in this personalized and interactive program that follows the stories and experiences of three cancer survivors who have participated in clinical trials.

Co-Pay Assistance Program Broadens Funding
Qualified patients with chronic myelogenous leukemia can now receive up to $5,000 in assistance from LLS' Co-Pay Assistance Program. The aid helps offset prescription drug co-pays and other insurance-related expenses according to disease diagnosis.

LLS Advocacy
LLS's advocacy team represents the needs of cancer patients and their families in Washington, DC and state capitals throughout the United States. We need your help. Join our Advocates Network and make your voice heard. 

Take Action: Urge Congress to Co-Sponsor Access to Cancer Clinical Trials

Find out about updates to COBRA covered by the Recovery Act signed into law on Feb. 17. 
 
Patient Services Survey
Please give us your feedback by completing LLS Disease & Treatment Publications - Survey for Patients, Family and Friends.

LLS Blog

Two New Promotions Support LLS's Mission

  • Bring LLS/TNT to your Mozilla Firefox Browser! Personalize your browser with LLS and TNT skins. Click here for details.
  • You can now have an LLS- or TNT-branded VISA credit card, personalized with any image you choose. LLS will receive $50 for each card used plus a percentage of all purchases. Click here for details.


The Leukemia & Lymphoma Society is committed to curing blood cancers and helping patients and their families.
Learn the many ways you can help advance LLS's mission. 
 


> Back to the top

Research Roundup

links_image_micro2


Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma  ::READ MORE:: 

Quality of life beyond 6 months after diagnosis in older adults with acute myeloid leukemia  ::READ MORE::

FLT3 inhibitors in acute myeloid leukemia  ::READ MORE::

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase  ::READ MORE::

A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group  ::READ MORE::

Amniotic fluid may provide new source of stem cells for future therapies  ::READ MORE::

> Back to the top

Clinical Trials
Clinical Trials Image Selected Trials

Phase III: Compare Bosutinib to Imatinib in Subjects with Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML  ::READ MORE::

Phase II/III: Efficacy and Safety Study of StemEx®, to Treat Subjects with High Risk Hematologic Malignancies, Following Myeloablative Therapy (ExCell)  ::READ MORE::

A Phase Ib Study of ISF35 in Combination With Chemotherapy (FCR) in Subjects With Relapsed, Refractory, and/or 17p- CLL  ::READ MORE::

Phase II Trial of CPX-351 in Newly Diagnosed Elderly AML Patients  ::READ MORE::

Phase III: A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families  ::READ MORE::

Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis  ::READ MORE::

> Back to the top

IRC Question of the Month: Pain Management Issues
Q&A

Q: I am being treated for leukemia. I'm taking pain medication prescribed by my doctor but I still have pain. What should I do?

A: Some patients with leukemia have disease and/or treatment-related pain. Having pain does not necessarily mean your cancer is getting worse. It's good that you have sought pain treatment to avoid additional health problems later on. And it's important that you continue to seek proper assessment and effective pain management throughout your treatment and recovery-untreated pain can suppress the immune system, delay healing and often leads to depression. 
 
There are two main types of pain: acute and chronic. People taking pain medication may also have "breakthrough pain" a brief, sometimes severe, flare of pain. Breakthrough pain can start as the pain medication is wearing off, before the next dose is due, or from a pain-producing activity or event. There are many options available to manage pain effectively. A combination of medications and non-drug options are often prescribed to provide relief. The approach used to manage your pain will depend on the cause and type of your pain.
 
Good communication will help your physician to understand and treat your pain. Because there is no objective measure, you play an important role in achieving good pain control. It's not unusual to find it difficult to talk about pain with the doctor. You might have trouble finding the right words to describe how the pain feels or you may worry about becoming addicted to pain medicine. You should know that patients with persistent pain who require prolonged opioid therapy, and take these medicines as directed, have little-to-no risk of developing addictive disease.
 
Remember that there are many ways to manage pain effectively. Tell your doctor if you have any side effects from your pain medication. Most side effects from pain medicine (for example, fatigue, gastrointestinal problems) can be managed. If your pain is not adequately controlled ask to be referred to a pain specialist. For more information on this topic, including suggestions for how to discuss pain with your doctor, read, print or order a free copy of the LLS Pain Management Fact Sheet at www.lls/org/freematerials or contact the Information Resource Center for a copy.
 
Is the Cost of Medication a Concern for You?
 
If so, discuss this with your doctor. He or she may assume that your medical insurance will cover all the costs. Your doctor may be able to prescribe less expensive medications or refer you to sources for financial aid. LLS offers a Patient Financial Aid Program to help with the cost of some medications, transportation and procedures for those in need. LLS also has a Co-Pay Assistance Program to help with the cost of insurance co-payments and/or insurance premium costs for prescription drugs for some blood cancers. Support for the Co-Pay Assistance Program is based on the availability of funds by disease diagnosis; patients must qualify both medically and financially.

Please call our Information Resource Center (IRC) to speak with a trained information specialist. IRC staff are available Monday through Friday, 9 a.m. to 6 p.m. ET, toll free at (800) 955-4572. Contact us online or click the "Live Patient Help" button on the www.LLS.org homepage.


> Back to the top

Supported by an unrestricted
educational grant from
Allos Therapeutics, Inc Cephalon Oncology
Donate Now
Contact Us: The Leukemia & Lymphoma Society, 1311 Mamaroneck Ave., White Plains, NY 10605, (800) 955-4572
Visit our e-Store & Special Offers page where you can support businesses that support LLS.